Testing effectiveness (Phase 2)Study completedNCT00915057What this trial is testingEffect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972.Who this might be right forHepatitis, Viral, Human Norgine 100
Not applicableLooking for participantsNCT05977283What this trial is testingHBsAg Declined Patients Follow-up StudyWho this might be right forHepatitis BHepatitis B, Chronic Nanfang Hospital, Southern Medical University 100
Post-approval studies (Phase 4)Ended earlyNCT01266005What this trial is testingCompare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV PatientsWho this might be right forChronic Hepatitis B Bukwang Pharmaceutical 75
Large-scale testing (Phase 3)Study completedNCT01192854What this trial is testingEfficacy and Safety of ClevudineWho this might be right forChronic Hepatitis B Eisai Co., Ltd. 288
Not applicableUnknownNCT02799316What this trial is testingIs Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?Who this might be right forHepatitis B Sherief Abd-Elsalam 100
Post-approval studies (Phase 4)UnknownNCT01834508What this trial is testing3E Extension StudyWho this might be right forChronic Hepatitis B Nanfang Hospital, Southern Medical University 600
Post-approval studies (Phase 4)Study completedNCT04294433What this trial is testingImmunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old ChildrenWho this might be right forHepatitis B Laval University 431
Post-approval studies (Phase 4)Study completedNCT00240526What this trial is testingLT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ MothersWho this might be right forHepatitis B GlaxoSmithKline 79
Not applicableStudy completedNCT01590615What this trial is testingRegistry Study for Patients With Chronic HBV Receiving Nucleotide TherapyWho this might be right forHepatitis B Gilead Sciences 54
Not applicableUnknownNCT03752658What this trial is testingTAF Real World Study for Universal EffectivenessWho this might be right forChronic Hepatitis b Tongji Hospital 500
Not applicableStudy completedNCT04182321What this trial is testingMetformin as Add-on to the Standard Therapy in Patients With Chronic Hepatitis BWho this might be right forChronic Hepatitis B Fu-Sheng Wang 60
Not applicableStudy completedNCT01623778What this trial is testingOptimization of Antiviral Therapy of Chronic HBV InfectionWho this might be right forAustralia Antigen PositiveHepatitis BAdverse Effects Changhai Hospital 67
Not applicableStudy completedNCT00199732What this trial is testingEvaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2aWho this might be right forChronic Hepatitis B University Hospital, Limoges 19
Testing effectiveness (Phase 2)Ended earlyNCT02604199What this trial is testingA Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) InfectionWho this might be right forHepatitis B Arrowhead Pharmaceuticals 58
Testing effectiveness (Phase 2)Study completedNCT02710604What this trial is testingPhase 2, Multiple Ascending Dose Proof of Concept StudyWho this might be right forInfectious Disease ContraVir Pharmaceuticals, Inc. 62
Not applicableLooking for participantsNCT04231565What this trial is testingNucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.Who this might be right forHepatitis B Virus Third Affiliated Hospital, Sun Yat-Sen University 200
Testing effectiveness (Phase 2)Ended earlyNCT04781647What this trial is testingA Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus InfectionWho this might be right forChronic Hepatitis B Assembly Biosciences 54
Large-scale testing (Phase 3)Study completedNCT01480258What this trial is testingSafety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)Who this might be right forBacterial InfectionsVirus Diseases MCM Vaccines B.V. 1,315
Not applicableActive Not RecruitingNCT06347588What this trial is testingRisk of Reactivation of Occult Hepatitis B in Cancer Patients During Immunotherapy.Who this might be right forOccult Hepatitis B Infection in Cancer Patients Fondazione IRCCS Policlinico San Matteo di Pavia 60
Large-scale testing (Phase 3)Study completedNCT01519960What this trial is testingPegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis BWho this might be right forHepatitis B, Chronic Hoffmann-La Roche 165